ABSTRACT
INTRODUCTION
Pathogenic fungi in the genus Candida can cause both superficial and serious systemic disease. Many Candida infections involve the formation of biofilms on implanted devices such as indwelling catheters or prosthetic heart valves. Biofilms of Candida albicans formed in vitro on catheter material consist of matrixenclosed micro colonies of yeasts and hyphae, arranged in a bilayer structure. The biofilms are resistant to commonly used antifungal agents like amphotericin B and fluconazole. In natural environments, many microorganisms exist predominantly as biofilms. Biofilms are structured microbial communities that are attached to a surface and encased in a matrix of exopolymeric material and are important in developing clinical infection. [1] One of the major factors contributing to the virulence of Candida is its ability in acclimatize to a variety of different habitats for growth and formation of surface-attached microbial communities known as "biofilms". Biofilms are defined as microbial communities encased in a matrix of extracellular polymeric substance (EPS), which display phenotypic features that differ from their planktonic or free-floating counterparts Individual microorganisms in biofilms are embedded within a matrix of often slimy extracellular polymer. The first example of a biofilm to be recognized in medical systems was a dental plaque on tooth surfaces, but recent estimates suggest that a substantial proportion of human infections involve biofilms. [2] Many of these are implant related infections in which adherent microbial populations are found on the surfaces of devices such as catheters, prosthetic heart valves and joint replacements. [3] A relatively small number of Candida species are pathogenic for humans. 
METHODS
A cross sectional study was planned at a tertiary care hospital at Navi Mumbai from January 2009 to February 2010. Specimens to be collected were sputum, urine, blood, bronchial secretions, endotracheal secretions, vaginal secretions and from endotracheal tubes and indwelling catheter tips. Inclusion criteria were that the specimens must be collected from critical care wards and the samples must be collected before any anti fungal treatment. The distribution of clinical specimens collected were as follows -Sputum (40), urine (40), blood (40), bronchial secretions (10), Endotracheal secretions (10),vaginal secretions (10), and devices like Endotracheal tubes (25) and Indwelling Catheter tips (25).
A standard KOH wet mount was performed followed by a Gram's staining on all specimens. Inoculation was carried out on Sabouraud's dextrose agar (SDA) and incubated at 37°C for 7 days or more if required.
Out of 200 specimens, those specimens which came positive for Candida were further processed for biofilm production. Biofilm production was determined by using a method proposed by Brachiniet al., wherein a loop full of organisms from the SDA was inoculated into a tube containing 10ml Sabouraud's liquid medium strains supplemented with glucose (to the final concentration of 8%). [4] The tubes were incubated at37°C for 24 h after which the broth was aspirated out and the walls of the tubes were stained with saffranin. Biofilm production was scored as negative (0), weak positive (1+), moderate positive (2+) and strong positive (3+). Data were entered in excel worksheets and analyzed using suitable statistical methods.
RESULTS
Candida species have the ability to cause a variety of superficial and deep seated mycoses. The present study shows the distribution of candida species in different clinical specimens and the predominance of candidia albicans in them.
Out of the total 200 clinical specimens, candida species were isolated from 88 specimens. Amongst these 88 positive specimens for Candida, majority were C. albicans (61.36%). The rest identified species in decreasing order were C. glabrata (15.9%), C. pseudotropicalis (13.64%) and C. paraspilosis (9.1%). Amongst the C. albicans, 68.51% showed moderate to strong positivity (2+ to 3+), whereas only 7.42% were negative for biofilm production. Isolates of C.albicans showed moderate to high biofilm production compared to the non albicans group. Majority of C.paraspilosis (62.5%), C. glabrata (64.28%) and C.pseudotropicalis (58.33%) showed weak positivity.
Amongst all the specimens collected for isolating Candida species, majority of the Candida were isolated from sputum (75%), bronchial secretions (60%), urine (45%) and blood (45%).
As shown in table 3, it can be said that out the total Candida isolates proportion of Candida albicans was more in this study as compared to Candida non albicans.
DISCUSSION
Biofilms are a protected niche for microorganisms, where they are safe from treatment and can create a source of persistent infection.
Candida albicans remains the fungal species most commonly associated with biofilm formation, and the increase in Candida infections in the last decades has almost paralleled the increase and widespread use of a broad range of medical implant devices, mainly in populations with impaired host defenses. [1,5,6 ] The formation of Candida biofilms carries important clinical repercussions because of their increased resistance to antifungal therapy and the ability of cells within biofilms to withstand host immune defenses. Also, biofilm formation on medical devices can negatively impact the host by causing the failure of the device and by serving as a reservoir or source for future continuing infections. [5] The net effect is that Candida biofilms adversely impact the health of these patients with increasing frequency and severity and with soaring economic squeal. [7] Quantitatively albicans spp. produces larger and more complex biofilms than any other spp. [8] Based on the results of this study, biofilmforming ability was found greater for albicans species, isolated from clinical specimens than the non albicans group of Candida.
CONCLUSION
The data suggests that the capacity of Candida species to produce biofilm appears to be a reflection of the pathogenic potential of the isolates. Isolates of Candida parapsilosis, Candida pseudotropicalisand Candida glabrata all gave significantly less biofilm growth then C. albicans.
